4.8 Article

Transcriptomic Analysis Reveals the MicroRNAs Responsible for Liver Regeneration Associated With Mortality in Alcohol-Associated Hepatitis

Journal

HEPATOLOGY
Volume 74, Issue 5, Pages 2436-2451

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1002/hep.31994

Keywords

-

Funding

  1. Translational Research and Evolving Alcoholic Hepatitis Treatment (TREAT) Consortium - National Institute on Alcohol Abuse and Alcoholism (NIAAA) [5U01AA021883-04, 5U01AA021891-04, 5U01AA021788-04, 5U01AA021840-04]
  2. Ralph W. and Grace M. Showalter Research Trust
  3. [R01DK107682]
  4. [R01AA025208]
  5. [U01 AA026917]
  6. [UH2/UH3 AA026903]
  7. [U01AA026817]
  8. [I01CX000361]
  9. [K01 AA026385]

Ask authors/readers for more resources

In patients with alcohol-associated hepatitis (AH), specific miRNAs are down-regulated while genes related to DNA synthesis and cell-cycle progression are up-regulated in an attempt to cope with hepatocyte injury. Higher expression of these miRNAs, indicating reduced liver regeneration capacity, predicts short-term mortality in AH patients.
Background and Aims We conducted a comprehensive serum transcriptomic analysis to explore the roles of microRNAs (miRNAs) in alcohol-associated hepatitis (AH) pathogenesis and their prognostic significance. Approach and Results Serum miRNA profiling was performed in 15 controls, 20 heavy drinkers without liver disease, and 65 patients with AH and compared to publicly available hepatic miRNA profiling in AH patients. Among the top 26 miRNAs, expression of miR-30b-5p, miR-20a-5p, miR-146a-5p, and miR-26b-5p were significantly reduced in both serum and liver of AH patients. Pathway analysis of the potential targets of these miRNAs uncovered the genes related to DNA synthesis and cell-cycle progression pathways, including ribonucleotide reductase regulatory subunit M2 (RRM2), cyclin D1 (CCND1), cyclin D2 (CCND2), MYC proto-oncogene (MYC), and phorbol-12-myristate-13-acetate-induced protein 1 (PMAIP1). We found a significant increase in the protein expression of RRM2, CCND1, and CCND2, but not MYC and PMAIP1, in AH patients who underwent liver transplantation; miR-26b-5p and miR-30b-5p inhibited the 3 '-UTR (untranslated region) luciferase activity of RRM2 and CCND2, and miR-20a-5p reduced the 3 '-UTR luciferase activity of CCND1 and CCND2. During a median follow-up of 346 days, 21% of AH patients died; these patients had higher body mass index (BMI), Model for End-Stage Liver Disease (MELD), and serum miR-30b-5p, miR-20a-5p, miR-146a-5p, and miR-26b-5p than those who survived. Cox regression analysis showed that BMI, MELD score, miR-20a-5p, miR-146a-5p, and miR-26b-5p predicted mortality. Conclusions Patients with AH attempt to deal with hepatocyte injury by down-regulating specific miRNAs and up-regulating genes responsible for DNA synthesis and cell-cycle progression. Higher expression of these miRNAs, suggestive of a diminished capacity in liver regeneration, predicts short-term mortality in AH patients.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available